| First Author | Li J | Year | 2022 |
| Journal | Free Radic Biol Med | Volume | 188 |
| Pages | 447-458 | PubMed ID | 35809767 |
| Mgi Jnum | J:332985 | Mgi Id | MGI:7326883 |
| Doi | 10.1016/j.freeradbiomed.2022.06.240 | Citation | Li J, et al. (2022) MTH1 suppression enhances the stemness of MCF7 through upregulation of STAT3. Free Radic Biol Med 188:447-458 |
| abstractText | MTH1 protein can sanitize the damaged (d)NTP pool and MTH1 inhibitors have been developed to impede the growth of rapidly proliferating tumor cells; however, the effect of MTH1 inhibition on breast cancer stemness has not been reported yet. Here, we constructed breast cancer cell lines with the stable depletion of MTH1. MTH1 suppression clearly increased the ratio of CD44(+)CD24(-/low) subpopulations and promoted the formation of tumorspheres in MCF7 and T47D cells. RNA expression profiling, RT-qPCR and Western blotting showed the upregulation of master stem cell transcription factors Sox2, Oct4 and Nanog in MTH1 knockdown cells. GSEA suggested and Western blotting verified that MTH1 knockdown increased the expression of phosphorylated STAT3 (Tyr705). Furthermore, we indirectly demonstrated that the increased concentration of 8-oxo-dGTP and 8-oxo-GTP in MTH1-knockdown cells and exogenous 8-oxoGTP, rather than 8-oxo-dGTP, could significantly increase the phosphorylation of STAT3. In conclusion, this work indicates that MTH1 inhibition increased the proportion of breast cancer stem cells (BCSCs) and promoted stemness properties in MCF7 cells. |
